Literature DB >> 23177074

Controversies in the care of the enterocutaneous fistula.

Kurt G Davis1, Eric K Johnson.   

Abstract

Enterocutaneous fistula and its variations are some of the most difficult problems encountered in the practice of general surgery. Reliable evidence that can be used to direct the care of patients afflicted with this malady is limited. There are controversies in several areas of care. This article addresses some of the gray areas of care for the patient with enterocutaneous fistula. There is particular attention directed toward the phenomenon of enteroatmospheric fistula, as well as prevention and abdominal wall reconstruction, which is often required in these individuals. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23177074     DOI： 10.1016/j.suc.2012.09.009

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  10 in total

Review 1.  Classification, prevention and management of entero-atmospheric fistula: a state-of-the-art review.

Authors:  Salomone Di Saverio; Antonio Tarasconi; Dominik A Walczak; Roberto Cirocchi; Matteo Mandrioli; Arianna Birindelli; Gregorio Tugnoli
Journal:  Langenbecks Arch Surg       Date:  2016-02-11       Impact factor: 3.445

Review 2.  Management of enteroatmospheric fistulae.

Authors:  Cem Terzi; Tufan Egeli; Aras E Canda; Naciye C Arslan
Journal:  Int Wound J       Date:  2014-06       Impact factor: 3.315

Review 3.  Enterocutaneous Fistula: Proven Strategies and Updates.

Authors:  Irena Gribovskaja-Rupp; Genevieve B Melton
Journal:  Clin Colon Rectal Surg       Date:  2016-06

4.  Polymorphism of heat shock protein 70-2 and enterocutaneous fistula in Chinese population.

Authors:  Jun Chen; Jian-An Ren; Gang Han; Guo-Sheng Gu; Ge-Fei Wang; Xiu-Wen Wu; Bo Zhou; Dong Hu; Yin Wu; Yun-Zhao Zhao; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

5.  Surgery for post-operative entero-cutaneous fistulas: is bowel resection plus primary anastomosis without stoma a safe option to avoid early recurrence? Report on 20 cases by a single center and systematic review of the literature.

Authors:  A Lauro; R Cirocchi; N Cautero; A Dazzi; D Pironi; F M Di Matteo; A Santoro; S Faenza; L Pironi; A D Pinna
Journal:  G Chir       Date:  2017 Jul-Aug

6.  Effect of Oral ω3-Polyunsaturated Fatty Acids as a Complement Management to Control Fistula Output and Inflammation in Patients With Digestive Fistula.

Authors:  José Luis Martínez-Ordaz; Ilka Boscó-Gárate; Arturo Cérbulo-Vázquez; Lourdes Arriaga-Pizano; Isabel Wong-Baeza; Patricio Sánchez-Fernandez; Constantino López-Macías; Armando Isibasi; Eduardo Ferat-Osorio
Journal:  J Gastrointest Surg       Date:  2016-12-01       Impact factor: 3.452

7.  The successful management for long-term intractable enteroatmospheric fistula: A case report.

Authors:  Kyota Tatsuta; Takeshi Oshima; Hisato Ishimatsu; Hiroyuki Hazama; Ko Ohata
Journal:  Ann Med Surg (Lond)       Date:  2020-07-30

8.  Management of enteroatmospheric fistula with negative pressure wound therapy in open abdomen treatment: a multicentre observational study.

Authors:  Adam Bobkiewicz; Dominik Walczak; Szymon Smoliński; Tomasz Kasprzyk; Adam Studniarek; Maciej Borejsza-Wysocki; Andrzej Ratajczak; Ryszard Marciniak; Michal Drews; Tomasz Banasiewicz
Journal:  Int Wound J       Date:  2016-03-22       Impact factor: 3.315

9.  Chronic mesh infection complicated by an enterocutaneous fistula successfully treated by infected mesh removal and negative pressure wound therapy: A case report.

Authors:  Hongquan Liu; Xiaochun Liu; Guofu Zheng; Bo Ye; Weiqing Chen; Hailiang Xie; Yunqiang Liu; Yi Guo
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

10.  Therapeutic Options in Postoperative Enterocutaneous Fistula-A Retrospective Case Series.

Authors:  Maria Mădălina Denicu; Dan Cartu; Mihai Ciorbagiu; Raducu Nicolae Nemes; Valeriu Surlin; Sandu Ramboiu; Luminița Cristina Chiuțu
Journal:  Medicina (Kaunas)       Date:  2022-06-30       Impact factor: 2.948
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.